LF

Luigi Franchi

FB First Wave Bio: 8 patents #2 of 3Top 70%
NA Novartis Ag: 4 patents #1,111 of 5,128Top 25%
📍 Ann Arbor, MI: #689 of 6,071 inventorsTop 15%
🗺 Michigan: #6,947 of 86,293 inventorsTop 9%
Overall (All Time): #370,096 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12084424 Compounds and compositions for treating conditions associated with NLRP activity Shomir Ghosh, Gary D. Glick, Jason Katz, Anthony Opipari, William R. Roush +4 more 2024-09-10
11793777 Methods and compositions for treating conditions associated with an abnormal inflammatory response Gary D. Glick 2023-10-24
11724992 Compounds and compositions for treating conditions associated with NLRP activity Shomir Ghosh, Gary D. Glick, Jason Katz, Anthony Opipari, William R. Roush +4 more 2023-08-15
11370763 Compounds and compositions for treating conditions associated with NLRP activity Shomir Ghosh, Gary D. Glick, Jason Katz, Anthony Opipari, William R. Roush +4 more 2022-06-28
11203579 Compounds and compositions for treating conditions associated with NLRP activity Shomir Ghosh, Gary D. Glick, Jason Katz, Anthony Opipari, William R. Roush +4 more 2021-12-21
10912746 Methods and compositions for treating conditions associated with an abnormal inflammatory response Gary D. Glick 2021-02-09
10905666 Methods and compositions for treating conditions associated with an abnormal inflammatory response Gary D. Glick 2021-02-02
10849867 Methods and compositions for treating conditions associated with an abnormal inflammatory response Gary D. Glick 2020-12-01
10799468 Methods and compositions for treating conditions associated with an abnormal inflammatory responses Gary D. Glick 2020-10-13
10772854 Methods and compositions for treating conditions associated with an abnormal inflammatory response Gary D. Glick, Giancarlo Santus 2020-09-15
10744103 Methods and compositions for treating conditions associated with an abnormal inflammatory responses Gary D. Glick 2020-08-18
10654816 Compounds and compositions for treating conditions associated with NLRP activity Shomir Ghosh, Gary D. Glick, Jason Katz, Anthony Opipari, William R. Roush +4 more 2020-05-19
10292951 Methods and compositions for treating conditions associated with an abnormal inflammatory responses Gary D. Glick, Giancarlo Santus 2019-05-21